What is the recommended treatment for withdrawal from marijuana or stimulants?

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

What is the recommended treatment for withdrawal from marijuana or stimulants?

Explanation:
Withdrawal from marijuana and stimulants is typically self-limiting, with symptoms resolving on their own within days to a couple of weeks. Because there isn’t a proven, universally recommended medication to treat these withdrawals, the best approach is supportive care that focuses on comfort, safety, hydration, nutrition, sleep, and access to counseling or behavioral support. In many cases, no specific detox medicine is needed, just reassurance and monitoring. Pharmacologic options listed in the choices aren’t appropriate for this withdrawal. A benzodiazepine taper isn’t routinely used as the standard treatment for cannabis or stimulant withdrawal and carries its own dependency risks. Naltrexone and disulfiram target opioid or alcohol pathways, not cannabis or stimulant withdrawal, so they don’t address the withdrawal symptoms these substances produce.

Withdrawal from marijuana and stimulants is typically self-limiting, with symptoms resolving on their own within days to a couple of weeks. Because there isn’t a proven, universally recommended medication to treat these withdrawals, the best approach is supportive care that focuses on comfort, safety, hydration, nutrition, sleep, and access to counseling or behavioral support. In many cases, no specific detox medicine is needed, just reassurance and monitoring.

Pharmacologic options listed in the choices aren’t appropriate for this withdrawal. A benzodiazepine taper isn’t routinely used as the standard treatment for cannabis or stimulant withdrawal and carries its own dependency risks. Naltrexone and disulfiram target opioid or alcohol pathways, not cannabis or stimulant withdrawal, so they don’t address the withdrawal symptoms these substances produce.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy